Navigation Links
MPF cup - Trio (Three Hole)

ProductsMPF cup - Trio (Three Hole)
Company Plus Orthopedics
Item MPF cup - Trio (Three Hole)
Features A unique triple radius profile, which combines an enhanced peripheral and reduced polar geometry, prevents bottoming out before achieving optimal peripheral fit. This ensures high primary stability in the periphery, where the cup is most stable and bone is the strongest. Combined with a proven titanium plasma sprayed surface and intuitive instrumentation, the MPF is a simple, highly effective options.
Description The MPF cup is specifically designed to achieve high primary stability, a critical factor for long term success.
Info Plus Orthopedics
Customer Service: (888) 741-7587
Web site: http://www.plusortho.com

Related medicine products :

1. MPF cup - Revision (Multi-Hole)
2. MPF cup - Standard (Zero Hole)
... insertion of Alcon Acrylic, Chiron/Iolab LI-41 and Pharmacia ... are taller and thinner, maximizing the surface area ... migration during loading and insertion, and makes it ... folded lens optic. The special direct-acting jaws release ...
Autoref / Ker N vision K 5001 has auto fogging, wide view window, near vision reading. Clear 5.6 Inch color monitor. Data screen function. SE Value display function. Quick printer with automatic cutt...
KR-8000 Supra is capable of obtaining perfectly accurate keratometry and/or refraction measurements through pupils as narrow as 2.0 mm....
... the child-friendly, portable autorefractor that tests ... It can perform objective refraction from ... away even through glasses and contact ... sounds engage the patient throughout the ...
Medicine Products:
(Date:4/1/2015)... April 01, 2015 South Florida’s newest ... Certificate of Authority (PCOA) approval from the State of ... the ongoing development of a retirement community that will ... wellness and spiritual development. , America’s aging population is ... the housing needs of seniors, according to a recent ...
(Date:4/1/2015)... (PRWEB) April 01, 2015 Like a ... is the scientific understanding of the potential causes of ... by the National Rosacea Society (NRS) to educate the ... treatable facial disorder now estimated to affect more than ... supported medical research on rosacea through its patient-funded research ...
(Date:4/1/2015)... Aging2.0 , the global innovation platform ... of the Aging2.0 Alliance – a new ... companies. The announcement was made today at the ... Forum in San Diego, CA. , Starting ... now open for additional members. “This is a unique ...
(Date:4/1/2015)... IQ Formulations , one of the ... companies in the U.S., today is commending GNC for taking ... standards for its herbal supplements.* GNC vowed that its new ... the accuracy of labeling on its products. , In ... Formulations CEO Jay Cohen said: , “In a ...
(Date:4/1/2015)... Beach, FL (PRWEB) April 01, 2015 ... programs, continues the expansion of its executive team with ... as chief digital officer. , In his ... subscription strategy and user interface across the business and ... distribution partners and building the company’s online community. ...
Breaking Medicine News(10 mins):Health News:Casa Sant’Angelo Receives Approval for New Retirement Living 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 2Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 3Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 4Health News:It’s Becoming Clear: Rosacea Awareness Month Highlights Potential Causes of Rosacea 5Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 2Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 3Health News:Aging2.0 Announces Launch of New Membership Community, Aging2.0 Alliance 4Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 2Health News:Addressing The Growing Demand for Interactive, Internet Mindfulness Programs, eMindful Expands Leadership Team With Top Digital Marketing Executive 3
... Self-Funding Healthcare Conference and Expo will provide employers and ... options during a June 1-3, 2009 conference in Kansas ... an employer rather than a conference promoter. ... the event to help educate employers and plan sponsors ...
... of imaging techniques, the accuracy of preoperative rectal cancer ... function in rectal cancer patients has become a very ... to be published on March 14, 2009 in the ... factors for 5-year survival after local excision of rectal ...
... typical backgrounds of the patients are diagnosed by radiological ... diagnostic imaging techniques. A typical LCA shows low density ... contrasting effect on arterial phase and does not show ... LCA in magnetic resonance imaging shows almost the same ...
... with atrial fibrillation. In the current edition of ... 164-70), Thomas Bitter and his coauthors from the Ruhr ... in this form of cardiac arrythmia and what the ... polygraphy to investigate whether 150 patients (110 men and ...
... Balance SheetATLANTA, March 20 In a time when ... healthcare centers are finding themselves in the same position ... of available financing is putting a damper on major ... the world,s leading manufacturers of oncology and neurosurgical devices ...
... March 20 Boehringer Ingelheim today announced that ... Phase III Randomized Evaluation of Long term Anticoagulant ... efficacy and safety of the oral direct thrombin ... warfarin (target international normalized ratio, INR, 2-3) for ...
Cached Medicine News:Health News:Deffenbaugh Industries to Host Self-Funding Healthcare Conference in Kansas City 2Health News:Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases 2Health News:Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases 3Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 2Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 3Health News:Final Patient Completes Treatment In Boehringer Ingelheim's RE-LY(R) Study, The Largest Atrial Fibrillation Outcomes Trial To Date 4
(Date:4/1/2015)... April 1, 2015 International Isotopes Inc. (OTCQB: ... year ended December 31, 2014.  The Company reports a ... loss, and positive cash flow for the year ended ... in 2014 was approximately $7.5 million compared to approximately ... approximately 10%.  With the exception of the radiological services ...
(Date:4/1/2015)... , April 1, 2015 ... Report on Global Azithromycin Industry and 2015 ... Industry reports added to Pharmaceutical category in ... the report introduces Azithromycin basic information, including ... overview, policy analysis, and news analysis, etc. ...
(Date:4/1/2015)... -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... Glucose Clamp Study. The study will be performed at ... San Antonio and University Health System,s ... Ralph DeFronzo . The glucose clamp is ...
Breaking Medicine Technology:International Isotopes Inc. Announces 2014 Year End Financial Results 2International Isotopes Inc. Announces 2014 Year End Financial Results 3International Isotopes Inc. Announces 2014 Year End Financial Results 4International Isotopes Inc. Announces 2014 Year End Financial Results 5International Isotopes Inc. Announces 2014 Year End Financial Results 6International Isotopes Inc. Announces 2014 Year End Financial Results 7Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 2Oramed Enrolls First Patient in its Glucose Clamp Study for Oral Insulin 3